Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Submitted by
admin
on October 17, 2011 - 9:30am
Source:
Bloomberg
News Tags:
warnings
Vivus
Qnexa
FDA
obesity
Headline:
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Do Not Allow Advertisers to Use My Personal information
